Putting patients at the heart of everything we do

Parexel is in the business of improving the world's health. As a leading CRO, we provide a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments.

About us

Management Team

Diversity, Equity and Inclusion

Decentralized Clinical Trials (DCTs)

The future is now!

We deliver DCTs with patients at the heart of our approach. Our fully virtual and hybrid DCTs (inclusive of home nursing) demonstrate the Parexel Promise – our commitment to treating patients and caregivers as an essential part of our team of clinical research organization experts.

Learn more

Navigating Long COVID Syndrome

During this time, we continue to be committed to our customers’ business while putting the safety of patients, partners and our employees at the heart of everything we do.

Long COVID Syndrome

COVID-19 Response

COVID-19 Data Clearinghouse

Roundtable: Three strategies for attracting early-stage investment

How can biotech companies plan their early development strategy to simultaneously position themselves for investment and address the needs of regulators? This panel of industry experts from Parexel Biotech, Health Advances, and Johnson & Johnson Innovation (JJDC) will provide lively discussion around how to make your company attractive to the outside world.

Learn more & Register

Four ways to increase rare disease drug development success

Only a small percentage of rare diseases have treatments readily available. Get the Parexel Biotech perspective on maximizing the chances of success and addressing some of the most significant challenges in rare disease drug development.

Download eBook